Berbice Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$392K Hold
1,100
– – 0.19% 36
2026
Q2
$531K Sell
1,100
-700
-39% -$186K 0.28% 37
2026
Q1
$197K Hold
1,800
– – 0.13% 52
2025
Q4
$299K Buy
1,800
+150
+9% +$25.1K 0.18% 46
2025
Q3
$323K Buy
1,650
+50
+3% +$8.22K 0.2% 46
2025
Q2
$145K Buy
1,600
+200
+14% +$15.8K 0.1% 61
2025
Q1
$83.5K Buy
1,400
+750
+115% +$69.4K 0.07% 68
2024
Q4
$86.1K Buy
+650
New +$61K 0.07% 67

Other funds holding ALAB

Berbice Capital Management's ALAB Position: Q3 2026 in Review

Berbice Capital Management held its Astera Labs (ALAB) position steady in Q3 2026 at 1,100 shares worth $392K. The position accounts for 0.19% of the portfolio, ranked #36.

Berbice Capital Management first reported a position in ALAB in Q4 2024 and has held it in 8 quarters since. The position peaked at $531K in Q2 2026. 353 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Berbice Capital Management held 1,100 shares of Astera Labs worth $392K as of Q3 2026.
  • Berbice Capital Management left its Astera Labs share count unchanged in Q3 2026.
  • Astera Labs made up 0.19% of Berbice Capital Management's portfolio in Q3 2026, its #36 holding.
  • Berbice Capital Management first reported a position in Astera Labs in Q4 2024 and has held it in 8 quarters since.
  • Berbice Capital Management's Astera Labs position peaked at $531K in Q2 2026.
  • 353 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Berbice Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.